Stephens Investment Management Group LLC / PCRX
Stephens Investment Management Group LLC’s Pacira Biosciences Inc Position
Does Stephens Investment Management Group LLC own Pacira Biosciences Inc (PCRX)? Not currently — the last reported position was 1.37M shares worth $39M in Q2 2024; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$39M
Q2 2024
Shares
1.37M
% of Portfolio
+0.55%
Quarters Held
23
position exited
Position History PCRX
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q2 2024 | 1.37M | $39M | +0.55% |
| Q1 2024 | 1.43M | $42M | +0.55% |
| Q4 2023 | 1.32M | $44M | +0.65% |
| Q3 2023 | 1.34M | $41M | +0.68% |
| Q2 2023 | 1.34M | $54M | +0.84% |
| Q1 2023 | 1.17M | $48M | +0.80% |
| Q4 2022 | 1.17M | $46M | +0.83% |
| Q3 2022 | 1.17M | $62M | +1.18% |
| Q2 2022 | 1.17M | $68M | +1.26% |
| Q1 2022 | 1.16M | $89M | +1.30% |
| Q4 2021 | 1.14M | $69M | +0.89% |
| Q3 2021 | 974.9K | $55M | +0.74% |
| Q2 2021 | 957.3K | $58M | +0.80% |
| Q1 2021 | 972.1K | $68M | +0.99% |
| Q4 2020 | 968.6K | $58M | +0.86% |
| Q3 2020 | 998.3K | $60M | +1.06% |
| Q2 2020 | 1.03M | $54M | +0.98% |
| Q1 2020 | 1.24M | $42M | +1.01% |
| Q4 2019 | 1.26M | $57M | +1.07% |
| Q3 2019 | 1.26M | $48M | +0.96% |
| Q2 2019 | 1.21M | $53M | +1.00% |
| Q1 2019 | 1.20M | $46M | +0.93% |
| Q4 2018 | 1.20M | $52M | +1.22% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Stephens Investment Management Group LLC’s full portfolio or all institutional holders of PCRX.